CXCR2-modified CAR-TÂ cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma.
Eur J Immunol. 2020 May;50(5):712-724. doi: 10.1002/eji.201948457. Epub 2020 Feb 10.
Eur J Immunol. 2020.
PMID: 31981231